Cargando…
Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
SIMPLE SUMMARY: To overcome the potential threat of drug resistance or limit of potency, the combination treatment of drugs is a promising strategy. Around 22% of patients with GCB-DLBCL carry EZH2 gain-of-function mutations and several PRC2 inhibitors are under clinical trials. Herein, we demonstra...
Autores principales: | Park, Sungryul, Jo, Seung-Hyun, Kim, Jong-Hwan, Kim, Seon-Young, Ha, Jae Du, Hwang, Jong Yeon, Lee, Myeong Youl, Kang, Jong Soon, Han, Tae-Su, Park, Sung Goo, Kim, Sunhong, Park, Byoung Chul, Kim, Jeong-Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565736/ https://www.ncbi.nlm.nih.gov/pubmed/32906688 http://dx.doi.org/10.3390/cancers12092541 |
Ejemplares similares
-
The Tumor Suppressor, p53, Negatively Regulates Non-Canonical NF-κB Signaling through miRNA-Induced Silencing of NF-κB–Inducing Kinase
por: Jang, Hanbit, et al.
Publicado: (2020) -
Hypoxia stabilizes SETDB1 to maintain genome stability
por: Park, Sungryul, et al.
Publicado: (2023) -
Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells
por: Zeng, Delong, et al.
Publicado: (2016) -
The Short-Chain Fatty Acid Receptor GPR43 Modulates YAP/TAZ via RhoA
por: Park, Bi-Oh, et al.
Publicado: (2021) -
Histone H4 is cleaved by granzyme A during staurosporine-induced cell death in B-lymphoid Raji cells
por: Lee, Phil Young, et al.
Publicado: (2016)